
Gastric Cancer Screening and Monitoring Marker
CA 72.4 is a tumor marker commonly used in the diagnosis and monitoring of gastric cancer (stomach cancer). It is a glycoprotein that is elevated in the blood of some individuals with gastric cancer. This test is also used to track treatment progress or detect recurrence in patients previously diagnosed with gastric cancer.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
Test Overview:
- Name: CA 72.4 (Cancer Antigen 72.4)
- Type: Tumor Marker
- Purpose:
- To detect gastric cancer, though it's not entirely specific and may be elevated in other cancers or benign conditions.
- To monitor treatment effectiveness or recurrence in individuals with known gastric cancer.
Risk Assessment:
- CA 72.4 is not a definitive test for diagnosing cancer. Elevated levels may indicate the presence of cancer, but they can also be raised in other conditions such as:
- Colorectal cancer
- Ovarian cancer
- Lung cancer
- Pancreatic cancer
- Benign conditions like gastrointestinal inflammation, liver diseases, and ovarian cysts.
A positive CA 72.4 test result needs to be interpreted alongside clinical evaluation, imaging tests, and other diagnostic markers. A normal or low result doesn’t rule out the presence of cancer, as some individuals with cancer may have normal levels of CA 72.4.
Normal Range: The normal value typically ranges from 0 to 6 U/mL (units per milliliter). This may vary depending on the laboratory and the test methods.
Interpretation:
- Normal Range: The normal value typically ranges from 0 to 6 U/mL (units per milliliter). This may vary depending on the laboratory and the test methods.
- Elevated CA 72.4 levels (greater than 6 U/mL) may indicate the presence of gastric cancer or other malignancies.
- However, high levels of CA 72.4 are not specific to gastric cancer, and false positives may occur due to other conditions (non-cancerous diseases, inflammation, etc.).
Sample Type:
- Blood Sample: The test is usually performed using a serum blood sample.
Frequently Asked Question
CA 72.4 (GASTRIC CANCER MARKER)
Gastric Cancer Screening and Monitoring Marker
CA 72.4 is a tumor marker commonly used in the diagnosis and monitoring of gastric cancer (stomach cancer). It is a glycoprotein that is elevated in the blood of some individuals with gastric cancer. This test is also used to track treatment progress or detect recurrence in patients previously diagnosed with gastric cancer.
Covid Safety
Assured
Free Report
Counselling